Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Journal of Contemporary Brachytherapy|December 4, 2024
Individualized 3D printing for skin cancer brachytherapy: Development, implementation, clinical applications, and treatment assessmentMichal Poltorak, Pawel Banatkiewicz, Lukasz Poltorak, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 9, 2024
Reproducibility and air gap pockets of 3D-printed brachytherapy applicator placement in high-dose-rate skin cancerMichal Poltorak, Pawel Banatkiewicz, Lukasz Poltorak, et al.
Postepy Dermatologii I Alergologii|September 12, 2022
Elastography as a possible useful method of assessment of skin involvement in systemic sclerosisPiotr Sobolewski, Monika Dźwigała, Jakub Zakrzewski, et al.
Life (Basel, Switzerland)|March 6, 2021
Correlation of the ALA-PDT Treatment Efficacy and the HPV Genotype Profile of Genital Warts after Cryotherapy Failure and Podophyllotoxin Therapy in Male PatientsWitold Owczarek, Monika Slowinska, Irena Walecka, et al.
Postepy Dermatologii I Alergologii|September 12, 2022
Skin manifestations of neuroendocrine neoplasms: review of the literatureIrena Walecka, Witold Owczarek, Piotr Ciechanowicz, et al.
Cancer Management and Research|August 20, 2025
Margin Involvement After Excision with Preoperative Dermoscopic Assessment of Head and Neck Basal Cell Carcinomas - a Retrospective StudyLaura Ziuzia-Januszewska, Irena Walecka, Małgorzata Kołos, et al.
Postepy Dermatologii I Alergologii|September 11, 2023
Hidradenitis suppurativa - biologic therapy and other available treatment optionsKatarzyna Lipa, Natalia Zając, Grzegorz Witkowski, et al.
Journal of Contemporary Brachytherapy|May 29, 2024
Brachytherapy and 3D printing for skin cancer: A review paperMichal Poltorak, Pawel Banatkiewicz, Lukasz Poltorak, et al.
Journal of Clinical Medicine|September 14, 2024
Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary CenterKonrad Lewandowski, Magdalena Kaniewska, Edyta Tulewicz-Marti, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 23, 2010
C-reactive protein as the indicator of severity in ovarian hyperstimulation syndromeMałgorzata Anna Nowicka, Anna Fritz-Rdzanek, Wojciech Grzybowski, et al.
Pageof 9